Other papers proved that systemic IL-17, through activation of the IL-6/Stat3 pathway and release of MMP2/9, TNF-α, and vascular endothelial factor (VEGF), induces tumor cell migration and metastatic growth in lung cancer-bearing mice [48,49,50]. This evidence concerns the gene IL6 and neoplasm.